Address & contact
https://en.chamc.co.kr/performance/research/stemcell.chaSpecialties
Reports that name this provider
- Stem Cell Therapy Quality in South Korea
- Among world's most prominent stem cell research institutions; achieved multiple global firsts including induced pluripotent stem cells (2009), cloning stem cell lines (2014), first Asian institution to publish clinical papers on embryonic stem cell-derived retinal disease therapy (2015); established embryonic stem cell lines compatible with approximately 25% of Korean population